Literature DB >> 8104628

Localization of the EPM1 gene for progressive myoclonus epilepsy on chromosome 21: linkage disequilibrium allows high resolution mapping.

A E Lehesjoki1, M Koskiniemi, R Norio, S Tirrito, P Sistonen, E Lander, A de la Chapelle.   

Abstract

The gene for Progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1) has previously been mapped by linkage to markers on chromosome 21q22.3. By analyzing crossover events in multiplex disease families with newly detected markers from the region we were able to narrow the localization of EPM1 to an interval of approximately 7 cM, between loci D21S212 and CD18. To further refine the localization of the EPM1 gene we applied linkage disequilibrium mapping in 38 Finnish families, consisting of 12 with multiple affected children and 26 with a single affected child. Based on existing knowledge about the structure and history of the isolated Finnish population, we estimated genetic distances based on strong linkage disequilibrium to several marker loci and found that EPM1 resides within 0.3 cM or less of loci PFKL, D21S25 and D21S154. As this genetic distance translates into a likely physical distance of 300 kb or less, these data provide a basis for highly focused attempts to clone EPM1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104628     DOI: 10.1093/hmg/2.8.1229

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

1.  QTL fine mapping by measuring and testing for Hardy-Weinberg and linkage disequilibrium at a series of linked marker loci in extreme samples of populations.

Authors:  H W Deng; W M Chen; R R Recker
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 2.  Finnish Disease Heritage I: characteristics, causes, background.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

3.  Identifying the susceptibility gene(s) in a set of trait-linked genes using genotype data.

Authors:  Ao Yuan; Guanjie Chen; Yuanxiu Chen; Charles Rotimi; George E Bonney
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

Review 4.  Linkage disequilibrium and association studies in higher plants: present status and future prospects.

Authors:  Pushpendra K Gupta; Sachin Rustgi; Pawan L Kulwal
Journal:  Plant Mol Biol       Date:  2005-03       Impact factor: 4.076

5.  Linkage disequilibrium mapping in isolated populations: the example of Finland revisited.

Authors:  A de la Chapelle; F A Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

6.  Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246.

Authors:  E N Levy; Y Shen; A Kupelian; L Kruglyak; I Aksentijevich; E Pras; J E Balow; B Linzer; X Chen; D A Shelton; D Gumucio; M Pras; M Shohat; J I Rotter; N Fischel-Ghodsian; R I Richards; D L Kastner
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Localization of the familial Mediterranean fever gene (FMF) to a 250-kb interval in non-Ashkenazi Jewish founder haplotypes. The French FMF Consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

8.  Progressive myoclonus epilepsy EPM1 locus maps to a 175-kb interval in distal 21q.

Authors:  K Virtaneva; J Miao; A L Träskelin; N Stone; J A Warrington; J Weissenbach; R M Myers; D R Cox; P Sistonen; A de la Chapelle
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

9.  The gene for severe combined immunodeficiency disease in Athabascan-speaking Native Americans is located on chromosome 10p.

Authors:  L Li; D Drayna; D Hu; A Hayward; S Gahagan; H Pabst; M J Cowan
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

10.  Genome scanning for segments shared identical by descent among distant relatives in isolated populations.

Authors:  L K Durham; E Feingold
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.